Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amibegron in Recurrent Major Depressive Episode
NCT00825019Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2003
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amibegron in major depressive disorder (MDD), sponsored by Sanofi. Started Sep 2003; status: completed.
02
Drugs
amibegron
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00825019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00825019.